ESR introduction and
outline ESR Project 10
Kinga is a biotechnologist, mainly trained in molecular biotechnology, cell biology, and genetic engineering. Studying Molecular Biotechnology at the University of Warmia and Mazury in Olsztyn (Poland), supported her interest in broad scientific topics. This resulted in two international traineeships in high profile institutes in Hamburg (Germany) that she completed during her Master's degree. Her first traineeship was taking place at the Heinrich Pette Institute (HPI) – Leibniz Institute for Experimental Virology, where she was working on the expression and protein purification of non-structural proteins of Coronaviruses. Her second traineeship was conducted at the Bernhard Nocht Institute for Tropical Medicine. Her project was focused on the production of infectious virus-like particles (iVLPs) to study Ebola virus replication in dendritic cells.
During the last semester of her Master's studies as well as after graduation, Kinga was working as a clinical research coordinator in the Center of Diagnostics and Eye Microsurgery – LENS in Olsztyn, where she was involved in conducting Phase III clinical trials for patients with Age-related Macular Degeneration (AMD) and glaucoma.
Since November 2019, Kinga is a Ph.D. student in the Institute of Experimental Pharmacology and Toxicology at the University Medical Center in Hamburg, Germany. In her project, she will be focusing on developing functional multicellular human engineered heart tissue (EHT). The center of her interest will be the role of macrophages in cardiac remodeling. This project is carried out under the supervision of Prof. Thomas Eschenhagen and co-supervision of Dr. Marc Hirt.
- Technical University Munich (group of Prof. Engelhardt, Institute for Pharmacology and Toxicology)
- Mirabilis Therapeutics BV (Dr Wit, pharmaceutical development)